Zurcher Kantonalbank (Zurich Cantonalbank) - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 164 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$153,634
+0.8%
6,874
-3.1%
0.00%0.0%
Q2 2023$152,407
-13.1%
7,092
-2.9%
0.00%0.0%
Q1 2023$175,295
+21.7%
7,307
+17.7%
0.00%0.0%
Q4 2022$144,072
+97.4%
6,210
+35.5%
0.00%
Q3 2022$73,000
-9.9%
4,5830.0%0.00%
Q2 2022$81,000
-12.9%
4,5830.0%0.00%
Q1 2022$93,000
+8.1%
4,5830.0%0.00%
Q4 2021$86,000
-4.4%
4,5830.0%0.00%
Q3 2021$90,000
-16.7%
4,5830.0%0.00%
-100.0%
Q2 2021$108,000
-0.9%
4,5830.0%0.00%0.0%
Q1 2021$109,000
+18.5%
4,5830.0%0.00%0.0%
Q4 2020$92,000
-3.2%
4,5830.0%0.00%0.0%
Q3 2020$95,000
+18.8%
4,5830.0%0.00%0.0%
Q2 2020$80,000
+135.3%
4,583
+121.8%
0.00%
Q1 2020$34,000
+78.9%
2,066
+126.0%
0.00%
Q4 2019$19,000
+90.0%
9140.0%0.00%
Q3 2019$10,000
-16.7%
9140.0%0.00%
Q2 2019$12,000
-14.3%
9140.0%0.00%
Q1 2019$14,000
-58.8%
914
-53.3%
0.00%
Q4 2018$34,000
+17.2%
1,9570.0%0.00%
Q3 2018$29,000
-38.3%
1,9570.0%0.00%
Q2 2018$47,000
-39.7%
1,957
-35.9%
0.00%
-100.0%
Q1 2018$78,000
+39.3%
3,0540.0%0.00%
Q4 2017$56,0003,0540.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q1 2021
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders